Macrogenics (MGNX) Revenue (2012 - 2026)

Macrogenics (MGNX) has 15 years of Revenue data on file, last reported at $20.8 million in Q1 2026.

• On a quarterly basis, Revenue rose 57.48% year-over-year to $20.8 million in Q1 2026; TTM through Mar 2026 was $157.1 million, a 10.08% decrease from a year earlier, with the FY2025 full-year figure at $149.5 million, changed 0.31% from the prior year.
• Revenue for Q1 2026 stood at $20.8 million, down from $41.2 million in the prior quarter.
• Over the last five years, Revenue for MGNX reached as high as $110.7 million in Q3 2024 and fell as low as $9.1 million in Q1 2024.
• Historically, Revenue has averaged $32.4 million across 5 years, with a median of $22.2 million in 2025.
• Across the five-year window, Revenue plunged 85.33% in 2023 and soared 964.81% in 2024, its largest moves.
• Year by year, Revenue stood at $73.1 million in 2022, then plunged by 85.33% to $10.7 million in 2023, then surged by 273.13% to $40.0 million in 2024, then grew by 3.07% to $41.2 million in 2025, then slumped by 49.61% to $20.8 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $20.8 million in Q1 2026, $41.2 million in Q4 2025, and $72.8 million in Q3 2025.